ASSOCIATION BETWEEN MYOCARDIAL BRIDGING AND CORONARY ARTERY DISEASE
Öz
Objective: Myocardial bridging is a congenital variant of a coronary artery in which a portion of an epicardial coronary artery takes an intramuscular course. Although it is considered as benign, it may lead to complications such as myocardial ischemia, acute coronary syndromes, coronary spasm, exercise-induced dysrhythmias or even sudden death. SYNTAX score is the angiographic scoring system and is commonly used to evaluate the severity and complexity of coronary artery disease. This study was conducted with the aim to evaluate the association between myocardial bridging and SYNTAX score.
Material and Methods: The medical records of consecutive patients, who underwent coronary artery bypass graft surgery, were retrospectively reviewed. The study group consisted of 267 patients. The prevalence of myocardial bridging was found to be 13.4%. Biochemical, clinical, echocardiographic parameters and SYNTAX score were evaluated in all patients. The patients were divided into two groups according to the SYNTAX score (≥23: high, <23 low).
Results: The High SYNTAX score group was older and had higher prevalence of hyperlipidemia, smoking, and diabetes mellitus. On univariate analysis age, diabetes mellitus, smoking, and hyperlipidemia were associated with higher SYNTAX score. On multivariate analysis diabetes mellitus and hyperlipidemia were independent predictors of higher SYNTAX score (OR 2.957; 95% CI: 1.391–5.183; p<0.001, OR 3.267; 95% CI: 1.973-6.739; p<0.001; respectively).
Conclusion: In our study, we have found that diabetes mellitus and hyperlipidemia were independent predictors of high SS. There was no significant difference between both groups regarding the presence of myocardial bridging.
Anahtar Kelimeler
Kaynakça
- 1. Geiringer E. The mural coronary. Am Heart J. 1951;41(3):359-68.
- 2. Bourassa MG, Butnaru A, Lesperance J, Tardif JC. Symptomatic myocardial bridges: overview of ischemic mechanisms and current diagnostic and treatment strategies. J Am Coll Cardiol. 2003;41(3):351-9.
- 3. Alegria JR, Herrmann J, Holmes DR Jr, Lerman A, Rihal CS. Myocardial bridging. Eur Heart J. 2005;26(12):1159-68.
- 4. De Giorgio F, Grassi VM, Polacco M, Pascali VL, d'Aloja E, Arena V. Myocardial bridging and sudden cardiac death: is the actual classification exhaustive? Int J Cardiol. 2014;172(3):383-4.
- 5. Migliore F, Maffei E, Perazzolo Marra M, Bilato C, Napodano M, Corbetti F et al. LAD coronary artery myocardial bridging and apical ballooning syndrome. JACC Cardiovasc Imaging. 2013;6(1):32-41.
- 6. Cerit L, Duygu H, Gulsen K. A case of doxazosin-induced acute coronary syndrome in a patient with myocardial bridging. Postepy Kardiol Interwencyjnej. 2016;12(1):75-6.
- 7. Uusitalo V, Saraste A, Pietila M, Kajander S, Bax JJ, Knuuti J. The functional effects of intramural course of coronary arteries and its relation to coronary atherosclerosis. JACC Cardiovasc Imaging. 2015:8(6):697-704.
- 8. Ishikawa Y, Akasaka Y, Ito K, Akishima Y, Kimura M, Kiguchi H et al. Significance of anatomical properties of myocardial bridge on atherosclerosis evolution in the left anterior descending coronary artery. Atherosclerosis. 2006:186(2):380-9.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Levent Cerit
*
0000-0002-2222-3681
Türkiye
Yayımlanma Tarihi
31 Ağustos 2019
Gönderilme Tarihi
14 Mart 2019
Kabul Tarihi
10 Ağustos 2019
Yayımlandığı Sayı
Yıl 2019 Cilt: 21 Sayı: 2